Amino.Desk

FGL (FG loop peptide)

Updated Nov 17, 2026 · Clinical review: pending

FGL is a peptide modeled on part of NCAM, a protein that helps nerve cells connect. It improved memory in rats and went through one human safety study as a nasal spray. No trial has shown that it works in people.

What it is

A synthetic peptide that copies a loop of the neural cell adhesion molecule. It activates a growth factor receptor on nerve cells. It was developed in Denmark as a possible treatment for Alzheimer's disease and other brain disorders.

What the evidence shows

Those studies measured safety. We found no published trial of whether it improves memory or any disease in people.

Legal status

Reported dosing

No dose has been established.

The Phase 1 study tested single nasal doses of 25, 100 and 200 mg, once, to look at safety. That is not a treatment schedule, and it is very different from the microgram amounts seller sites describe.

Safety

Common questions

Has FGL been tested in humans?

Yes, for safety only: single nasal doses in 24 healthy men.

Does FGL improve memory?

It did in rats. No human trial has tested that.

Is FGL FDA-approved?

No.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy